22
Jun
2017
Repare Secures $68M Series A to Discover ‘Synthetic Lethal’ Cancer Drugs
This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account. 
Share:
21
Jun
2017
Rubius Snags $120M to Engineer Red Blood Cell Therapies Off The Shelf
This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.
Share:
19
Jun
2017
An American Sickness: A Skillful Deconvolution of the U.S. Healthcare Mess
This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.
Share:
16
Jun
2017
Supreme Court Speeds Biosimilars, Clancy’s Lucrative Switch, & Apple Sniffs Around Health Records
This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.
Share:
12
Jun
2017
Long-Distance Relationships in Biotech Startups: How to Make Them Work
This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.
Share:
9
Jun
2017
FDA Drops Opioid Hammer, Collins Stays at NIH, & Pfizer’s Relentless Ratcheting
This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.
Share:
9
Jun
2017
ASCO Takeaways A-Z (Part 2)
This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.
Share:
8
Jun
2017
ASCO Takeaways From A-Z (Part 1)
This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.
Share:
5
Jun
2017
ASCO Notebook: Observations on Cancer R&D from Foundation Medicine, Halozyme, Blueprint, Nektar
This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.
Share:
2
Jun
2017
State AGs Pull Knives on Pharma, Grail Grows by Acquisition, CRISPR Jitters
This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.
Share:
1
Jun
2017
Atlas Venture Lures Rising Star Away from Polaris
This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.
Share:
26
May
2017
Alexion Expose, a Historic First at FDA, and Puma’s Come-From-Behind Victory
This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.
Share:
25
May
2017
12 VCs Who Matter, But You Never Read About
This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.
Share:
19
May
2017
A Biotech Pioneer Leaves Us, Verily Hires Ex-FDA Commish, Amazon Prowling Pharma
This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.
Share:
18
May
2017
Former Sarepta CEO Gets $15M From Hedge Fund for Startup Incubator
This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.
Share:
16
May
2017
Biotech People Care, But How Can the Industry Make a Difference?
This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.
Share:
12
May
2017
Palpitations in PD-1/PD-L1 Land, a Mystery ALS Drug Approval, And a CAR-T Scare
This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.
Share:
8
May
2017
Seattle Biotech: See You at the TR 2nd Anniversary Party Tuesday at Adaptive
Seattle biotech, you’ve been with me on this journey since Day 1. Since Timmerman Report was founded in 2015, it has gone against the grain of the media economy in many ways. You put your faith in me that I’d deliver high-quality biotech journalism and analysis, and I’ve worked hard to deliver the goods. Good news: TR is not only still...Read More
Share:
5
May
2017
House Passes Trumpcare, Alzheimer’s Drug Shenanigans, & An IPO Flurry
This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.
Share:
1
May
2017
Who’s Doing What in Long-Read and Linked-Read DNA Sequencing
This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.
Share:
